Alnylam Pharmaceuticals Inc., (ALNY) discovers, develops & commercializes therapeutics based on ribonucleic acid interference. It comes under Healthcare – Biotech sector & trades as “ALNY” ticker at Nasdaq.
ALNY favors rally in bullish weekly sequence & expect continuation against April-2025 low. It favors rally in ((3)) of III against 4.07.2025 low & pullback in 3, 7 or 11 swings offers buying opportunity.
ALNY - Elliott Wave Latest Weekly View: 
It ended ((I)) at $140 high since inception in June-2025 & ((II)) pullback at $31.38 low in October-2016. Above there, it is showing nest as the part of (III) of ((III)). It placed (I) of ((III)) at $153.99 high in March-2018 & (II) at $60.27 low in December-2018. Within (III), it placed I at $242.97 high in December-2022 as diagonal & II at $141.97 low in April-2024. It placed ((1)) at $212 high, ((2)) at $117.58 low, ((3)) at $236.80 high, ((4)) at $181.65 low & ((5)) at $242.97 high. It corrected II in zigzag correction ended at 0.50 Fibonacci retracement of I.
Above April-2024 low, it gapped up with ((1)) of III that broke price channel with high momentum. It ended ((1)) of III at $304.39 high in October-2024. It ended ((2)) pullback at $205.87 low in 3 swings correction at $205.87 low on 4.07.2025. Within ((2)), it placed (A) at $229.85 low, (B) at $300.90 high & (C) at $205.87 low in blue box area. It already broke to new high in (1) & expect small upside before pullback in (2) of ((3)). We like to buy the pullback of (2) in 3, 7 or 11 swings at extreme area, when reach. Later, we expect (3) to extend higher & erase momentum divergence to confirm rally to be ((3)) towards $368.5 - $469.3 area. Alternatively, if new high comes with momentum divergence, then it can be diagonal of ((1)) in 5 swings, before correcting against April-2024 low.
إخلاء المسؤولية: الآراء الواردة هنا تعبر فقط عن رأي الكاتب، ولا تمثل الموقف الرسمي لـ Followme. لا تتحمل Followme مسؤولية دقة أو اكتمال أو موثوقية المعلومات المُقدمة، ولا تتحمل مسؤولية أي إجراءات تُتخذ بناءً على المحتوى، ما لم يُنص على ذلك صراحةً كتابيًا.
